Sökning: onr:"swepub:oai:DiVA.org:oru-33808" > The development of ...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 03647naa a2200373 4500 | |
001 | oai:DiVA.org:oru-33808 | |
003 | SwePub | |
008 | 140218s2014 | |||||||||||000 ||eng| | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-338082 URI |
024 | 7 | a https://doi.org/10.3920/BM2012.00692 DOI |
040 | a (SwePub)oru | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a for2 swepub-publicationtype |
100 | 1 | a Mekkes, M. C.u Athena Inst, Vrije Univ, Amsterdam, Netherlands4 aut |
245 | 1 0 | a The development of probiotic treatment in obesity :b a review |
264 | 1 | a Wageningen :b Wageningen Academic Publishers,c 2014 |
338 | a print2 rdacarrier | |
520 | a Recent studies suggested that manipulation of the composition of the microbial ecosystem in the gut might be a novel approach in the treatment of obesity. Such treatment might consist of altering the composition of the microbial communities of an obese individual by administration of beneficial microorganisms, commonly known as probiotics. Here, we intend to contribute to the developmental process of probiotic treatment of human obesity. The aim is to review the evidence regarding the potential effect of probiotic strains on reduction of weight and body fat. A literature study was conducted focusing on clinical trials that examined the effect of specific microorganisms on body weight control. Analysis of the eligible articles pointed out that Lactobacillus gasseri SBT 2055, Lactobacillus rhamnosus ATCC 53103, and the combination of L. rhamnosus ATCC 53102 and Bifidobacterium lactis Bb12 may reduce adiposity, body weight, and weight gain. This suggests that these microbial strains can be applied in the treatment of obesity. Furthermore, short chain fatty acid production and low grade inflammation were found as the underlying mechanisms of action that influence metabolism and affect body weight. These findings might contribute to the development of probiotic treatment of obesity. Further research should be directed to the most effective combination and dosage rate of probiotic microorganisms. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Medicinska och farmaceutiska grundvetenskaperx Mikrobiologi inom det medicinska området0 (SwePub)301092 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Basic Medicinex Microbiology in the medical area0 (SwePub)301092 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Hälsovetenskapx Näringslära0 (SwePub)303042 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Health Sciencesx Nutrition and Dietetics0 (SwePub)303042 hsv//eng |
653 | a microbiota; clinical studies; microbial strain; mechanism of action; metabolism; obesity | |
653 | a Microbiology | |
653 | a Mikrobiologi | |
700 | 1 | a Weenen, T. C.u Erasmus Sch Econ Rotterdam, Erasmus Universiteit Rotterdam, Rotterdam, Netherlands; Erasmus MC, Rotterdam, Netherlands4 aut |
700 | 1 | a Brummer, Robert J.,d 1957-u Örebro universitet,Institutionen för läkarutbildning,Region Örebro län4 aut0 (Swepub:oru)rnbr |
700 | 1 | a Claassen, E.u Athena Inst, Vrije Univ, Amsterdam, the Netherlands; Erasmus MC Rotterdam, Rotterdam, Netherlands4 aut |
710 | 2 | a Athena Inst, Vrije Univ, Amsterdam, Netherlandsb Erasmus Sch Econ Rotterdam, Erasmus Universiteit Rotterdam, Rotterdam, Netherlands; Erasmus MC, Rotterdam, Netherlands4 org |
773 | 0 | t Beneficial Microbesd Wageningen : Wageningen Academic Publishersg 5:1, s. 19-28q 5:1<19-28x 1876-2883x 1876-2891 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-33808 |
856 | 4 8 | u https://doi.org/10.3920/BM2012.0069 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy